Peningkatan Kadar Lipoprotein-Associated Phospholipase A2 Meningkatkan Kejadian Stroke Iskemik Akut

Syarif Indra


Introduction: Stroke is a major health problem in the world, and associated with mortality, disability, and economic burden. Stroke is the second leading cause of death in the world after heart disease and cause of disability in adults. Several recent studies show that levels of Lp-PLA2 contribute to high serum lead to ischemic stroke, whereas some others do not get the association. Aims: studies an association between serum Lp-PLA2 with incident ischemic stroke. Method: This study is a descriptive analytic comparative with cross sectional design in the Neurology ward RS. DR. M. Djamil Padang between October 2013 to April 2014 with total of 88 subjects consisting of 44 subjects ischemic stroke patients and 44 healthy control group who participated in the study. Statistical analysis is used parametric test with unpaired t test, test for normality with the Kolmogorov-Smirnov test, and logistic regression analysis. Result: P value 0.05 was considered statistically significant. The mean age of subjects in the group of ischemic stroke patients was 57.30 ±8.86 years old. Female in patients with ischemic stroke group was 23 people (52,3%). Mean levels of Lp-PLA2 serum in patiens with ischemic stroke group was 103.49±48.00 ng/mL. A significan association between serum levels of Lp-PLA2 with incident ischemic stroke with p<0.05. Conclusion: There was a significant relation in elevation of serum Lp-PLA2 levels with incident of ischemic stroke.


serum Lp-PLA2, ischemic stroke

Full Text:



Zhou F, Liu Y, Shi H, Huang Q, Zhou J. Relation between lipoprotein-associated phospholipase A2 mass and incident ischemic stroke severity.Springer Neurological Science. 2018

Huang Fubao, Wang K, Shen J. 2019.Lipoprotein‐associated phospholipase A2:The story continues. Wiley Online Library

Li D, Wei W, et al. 2017.Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis. Elsevier

Monbailliu T, Gossens J,Hachimi-Idrissi S. 2017.Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review.Biomarkers in Medicine.

Bejot Y, Bailly H, Durier J,Giroud M. 2016.Epidemiology of stroke in Europe and trends for the 21st century. Presse Med

Garg P K, Norby F L, et al. 2018. Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC).Elsevier

Hu G, Liu D, Tong H, Huang W, Hu Y, Huang Y. 2019.Lipoprotein-Associated Phospholipase A2 Activity and Mass as Independent Risk Factor of Stroke: A Meta-Analysis. BioMed Research International

Tian Y, Jia H, Li S, Wu Y, Guo L,Tan G, Li B..The associations of stroke, transient ischemic attack, and/or stroke-related recurrent vascular events with Lipoprotein-associated phospholipase A2 : A systematic review and meta-analysis.Medicine.2017

Dhamoon M S, Cheung Y K, Moon Y P, Wright Y B, Sacco R L, Elkind M S V. 2019. Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.PLOSONE

Khoshnam S E,Winlow W, Farzaneh M.2017.The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke. American Association of Neurophatologist.

Rasyid A, Harris S, Kurniawan M, Mesiano T. Buku Ajar Neurologi: Stroke Iskemik. Fakultas Kedokteran Universitan Indonesia; 2017

Caplan,L.R Caplan Stroke :A Clinical Approach.4th ed. United State of Amerika : Saunder Elsevier. 2009

Katan M, Moon Y P, Paik M C, Wolfert R L, Sacco R L, Elkind M S V. 2014. Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study

Wang Y, Hu S, Ren L, Lei Z., Lan T, Cai J, Li C. 2018. Lp-PLA2 as a risk factor of early neurological deterioration in acute ischemic stroke with TOAST type of large arterial atherosclerosis

Lin J, Zheng H, Cucchiara BL, et al. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke. Neurology. 2015

Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics‐2018 update: a report from the American Heart Association. Circulation. 2018

Benderly M, Sapir B, Kalter-Leibovici O, et al. Lipoprotein-associated phospholipase A2, and subsequent cardiovascular events and mortality among patients with coronary heart disease. Biomarkers. 2017

Wei L, Ke Z, Zhao Y, et al. The elevated lipoproteinassociated phospholipase A2 activity is associated with the occurrence and recurrence of acute cerebral infarction. Neuroreport. 2017

Ueshima H, Kadowaki T, Hisamatsu T, et al. Lipoprotein‐associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population. Atherosclerosis. 2016

Gregson JM, Freitag DF, Surendran P, et al. Genetic invalidation of Lp‐PLA2 as a therapeutic target: large‐scale study of five functional Lp‐PLA2‐lowering alleles. Eur J Preventive Cardiol. 2017



  • There are currently no refbacks.

Copyright (c) 2021 Health & Medical Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Creative Commons License   Health and Medical Journal This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.